Mestranol Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Type (Kit, Tablet); End User (Abnormal, Uterine Bleeding, Endometriosis, Hypermenorrhea, Menstrual Cramps, Polycystic Ovarian Syndrome) and Geography

Report Code: TIPRE00019311 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

Mestranol is an estrogen medication that is used in birth control pills, menopausal hormone therapy, and the treatment of menstrual disorders. It is produced in combination with a progestin and is not available alone.

MARKET DYNAMICS

Factors like rising gynaecological disorders and the increasing awareness to prevent pregnancy among the population propel the mestranol market growth. However, side effects like high blood pressure and glucose intolerance on mestranol consumption will hamper the market growth.

MARKET SCOPE

The "Mestranol Market Analysis to 2027" is a specialized and in-depth study of the Pharmaceuticals industry with a special focus on the global market trend analysis. The report aims to provide an overview of mestranol market with detailed market segmentation with type and application. The mestranol market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in mestranol market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The mestranol market is segmented on the basis of type and application. On the basis of type, the mestranol market is divided into kit and tablet. Based on application, the mestranol market can be segmented as abnormal uterine bleeding, endometriosis, hypermenorrhea, menstrual cramps and polycystic ovarian syndrome.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the mestranol market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The mestranol market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyses factors affecting mestranol market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors affecting the mestranol market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in mestranol market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from mestranol market are anticipated to have lucrative growth opportunities in the future with the rising demand for mestranol in the global market. Below mentioned is the list of few companies engaged in the mestranol market.

The report also includes the profiles of key players in mestranol market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered financial information of last 3 years, key development in past five years.

  •  Johnson and Johnson
  •  Teva Pharmaceutical Industries Ltd.
  •  Pfizer Inc.
  •  ASKA Pharmaceutical Co., Ltd.
  •  LGM Pharma.
  •  Merck KGaA
  •  GlaxoSmithKline plc
  •  Sanofi S.A.
  •  Eli Lilly and Company
  •  Thai Nakorn Patana Co., Ltd.

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Mestranol Market - By Type
1.3.2 Mestranol Market - By End User
1.3.3 Mestranol Market - By Region
1.3.3.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. MESTRANOL MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. MESTRANOL MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. MESTRANOL MARKET - GLOBAL MARKET ANALYSIS
6.1. MESTRANOL - GLOBAL MARKET OVERVIEW
6.2. MESTRANOL - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE

7. MESTRANOL MARKET - REVENUE AND FORECASTS TO 2027 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. KIT
7.3.1. Overview
7.3.2. Kit Market Forecast and Analysis
7.4. TABLET
7.4.1. Overview
7.4.2. Tablet Market Forecast and Analysis
8. MESTRANOL MARKET - REVENUE AND FORECASTS TO 2027 - END USER
8.1. OVERVIEW
8.2. END USER MARKET FORECASTS AND ANALYSIS
8.3. ABNORMAL
8.3.1. Overview
8.3.2. Abnormal Market Forecast and Analysis
8.4. UTERINE BLEEDING
8.4.1. Overview
8.4.2. Uterine Bleeding Market Forecast and Analysis
8.5. ENDOMETRIOSIS
8.5.1. Overview
8.5.2. Endometriosis Market Forecast and Analysis
8.6. HYPERMENORRHEA
8.6.1. Overview
8.6.2. Hypermenorrhea Market Forecast and Analysis
8.7. MENSTRUAL CRAMPS
8.7.1. Overview
8.7.2. Menstrual Cramps Market Forecast and Analysis
8.8. POLYCYSTIC OVARIAN SYNDROME
8.8.1. Overview
8.8.2. Polycystic Ovarian Syndrome Market Forecast and Analysis

9. MESTRANOL MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Mestranol Market Overview
9.1.2 North America Mestranol Market Forecasts and Analysis
9.1.3 North America Mestranol Market Forecasts and Analysis - By Type
9.1.4 North America Mestranol Market Forecasts and Analysis - By End User
9.1.5 North America Mestranol Market Forecasts and Analysis - By Countries
9.1.5.1 United States Mestranol Market
9.1.5.1.1 United States Mestranol Market by Type
9.1.5.1.2 United States Mestranol Market by End User
9.1.5.2 Canada Mestranol Market
9.1.5.2.1 Canada Mestranol Market by Type
9.1.5.2.2 Canada Mestranol Market by End User
9.1.5.3 Mexico Mestranol Market
9.1.5.3.1 Mexico Mestranol Market by Type
9.1.5.3.2 Mexico Mestranol Market by End User
9.2. EUROPE
9.2.1 Europe Mestranol Market Overview
9.2.2 Europe Mestranol Market Forecasts and Analysis
9.2.3 Europe Mestranol Market Forecasts and Analysis - By Type
9.2.4 Europe Mestranol Market Forecasts and Analysis - By End User
9.2.5 Europe Mestranol Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Mestranol Market
9.2.5.1.1 Germany Mestranol Market by Type
9.2.5.1.2 Germany Mestranol Market by End User
9.2.5.2 France Mestranol Market
9.2.5.2.1 France Mestranol Market by Type
9.2.5.2.2 France Mestranol Market by End User
9.2.5.3 Italy Mestranol Market
9.2.5.3.1 Italy Mestranol Market by Type
9.2.5.3.2 Italy Mestranol Market by End User
9.2.5.4 Spain Mestranol Market
9.2.5.4.1 Spain Mestranol Market by Type
9.2.5.4.2 Spain Mestranol Market by End User
9.2.5.5 United Kingdom Mestranol Market
9.2.5.5.1 United Kingdom Mestranol Market by Type
9.2.5.5.2 United Kingdom Mestranol Market by End User
9.2.5.6 Rest of Europe Mestranol Market
9.2.5.6.1 Rest of Europe Mestranol Market by Type
9.2.5.6.2 Rest of Europe Mestranol Market by End User
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Mestranol Market Overview
9.3.2 Asia-Pacific Mestranol Market Forecasts and Analysis
9.3.3 Asia-Pacific Mestranol Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Mestranol Market Forecasts and Analysis - By End User
9.3.5 Asia-Pacific Mestranol Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Mestranol Market
9.3.5.1.1 Australia Mestranol Market by Type
9.3.5.1.2 Australia Mestranol Market by End User
9.3.5.2 China Mestranol Market
9.3.5.2.1 China Mestranol Market by Type
9.3.5.2.2 China Mestranol Market by End User
9.3.5.3 India Mestranol Market
9.3.5.3.1 India Mestranol Market by Type
9.3.5.3.2 India Mestranol Market by End User
9.3.5.4 Japan Mestranol Market
9.3.5.4.1 Japan Mestranol Market by Type
9.3.5.4.2 Japan Mestranol Market by End User
9.3.5.5 South Korea Mestranol Market
9.3.5.5.1 South Korea Mestranol Market by Type
9.3.5.5.2 South Korea Mestranol Market by End User
9.3.5.6 Rest of Asia-Pacific Mestranol Market
9.3.5.6.1 Rest of Asia-Pacific Mestranol Market by Type
9.3.5.6.2 Rest of Asia-Pacific Mestranol Market by End User
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Mestranol Market Overview
9.4.2 Middle East and Africa Mestranol Market Forecasts and Analysis
9.4.3 Middle East and Africa Mestranol Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Mestranol Market Forecasts and Analysis - By End User
9.4.5 Middle East and Africa Mestranol Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Mestranol Market
9.4.5.1.1 South Africa Mestranol Market by Type
9.4.5.1.2 South Africa Mestranol Market by End User
9.4.5.2 Saudi Arabia Mestranol Market
9.4.5.2.1 Saudi Arabia Mestranol Market by Type
9.4.5.2.2 Saudi Arabia Mestranol Market by End User
9.4.5.3 U.A.E Mestranol Market
9.4.5.3.1 U.A.E Mestranol Market by Type
9.4.5.3.2 U.A.E Mestranol Market by End User
9.4.5.4 Rest of Middle East and Africa Mestranol Market
9.4.5.4.1 Rest of Middle East and Africa Mestranol Market by Type
9.4.5.4.2 Rest of Middle East and Africa Mestranol Market by End User
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Mestranol Market Overview
9.5.2 South and Central America Mestranol Market Forecasts and Analysis
9.5.3 South and Central America Mestranol Market Forecasts and Analysis - By Type
9.5.4 South and Central America Mestranol Market Forecasts and Analysis - By End User
9.5.5 South and Central America Mestranol Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Mestranol Market
9.5.5.1.1 Brazil Mestranol Market by Type
9.5.5.1.2 Brazil Mestranol Market by End User
9.5.5.2 Argentina Mestranol Market
9.5.5.2.1 Argentina Mestranol Market by Type
9.5.5.2.2 Argentina Mestranol Market by End User
9.5.5.3 Rest of South and Central America Mestranol Market
9.5.5.3.1 Rest of South and Central America Mestranol Market by Type
9.5.5.3.2 Rest of South and Central America Mestranol Market by End User

10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

11. MESTRANOL MARKET, KEY COMPANY PROFILES
11.1. JOHNSON AND JOHNSON
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. TEVA PHARMACEUTICAL INDUSTRIES LTD.
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. PFIZER INC.
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. ASKA PHARMACEUTICAL CO., LTD.
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. LGM PHARMA.
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. MERCK KGAA
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. GLAXOSMITHKLINE PLC
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. SANOFI S.A.
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. ELI LILLY AND COMPANY
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. THAI NAKORN PATANA CO., LTD.
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments

12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1.Johnson and Johnson
2.Teva Pharmaceutical Industries Ltd.
3.Pfizer Inc.
4.ASKA Pharmaceutical Co., Ltd.
5.LGM Pharma.
6.Merck KGaA
7.GlaxoSmithKline plc
8.Sanofi S.A.
9.Eli Lilly and Company
10.Thai Nakorn Patana Co., Ltd.
TIPRE00019311
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking